Correlation Between Blueprint Medicines and Ultragenyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Ultragenyx, you can compare the effects of market volatilities on Blueprint Medicines and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Ultragenyx.

Diversification Opportunities for Blueprint Medicines and Ultragenyx

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Blueprint and Ultragenyx is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Ultragenyx go up and down completely randomly.

Pair Corralation between Blueprint Medicines and Ultragenyx

Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 1.33 times more return on investment than Ultragenyx. However, Blueprint Medicines is 1.33 times more volatile than Ultragenyx. It trades about 0.22 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.32 per unit of risk. If you would invest  8,440  in Blueprint Medicines Corp on August 24, 2024 and sell it today you would earn a total of  1,317  from holding Blueprint Medicines Corp or generate 15.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Blueprint Medicines Corp  vs.  Ultragenyx

 Performance 
       Timeline  
Blueprint Medicines Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Blueprint Medicines Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Blueprint Medicines is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Blueprint Medicines and Ultragenyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Blueprint Medicines and Ultragenyx

The main advantage of trading using opposite Blueprint Medicines and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.
The idea behind Blueprint Medicines Corp and Ultragenyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum